Vaxcyte, Inc. — Director's Dealing 2021

Oct 30, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vaxcyte, Inc. (PCVX)
CIK: 0001649094
Period of Report: 2021-10-27

Reporting Person: Paya Carlos V (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-10-27	Stock Option (Right to Buy)	$22.02	A	30000	Acquired	2031-10-26	Common Stock (30000)	Direct

Footnotes

F1: Option shall vest over 36 months, 1/3 of which will vest on October 27, 2022 and 1/36 of which will vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date